C. Alm

1.1k total citations
15 papers, 764 citations indexed

About

C. Alm is a scholar working on Pharmacology, Pharmacology and Oncology. According to data from OpenAlex, C. Alm has authored 15 papers receiving a total of 764 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pharmacology, 3 papers in Pharmacology and 3 papers in Oncology. Recurrent topics in C. Alm's work include Pharmacogenetics and Drug Metabolism (8 papers), Cancer Treatment and Pharmacology (3 papers) and Pharmacology and Obesity Treatment (2 papers). C. Alm is often cited by papers focused on Pharmacogenetics and Drug Metabolism (8 papers), Cancer Treatment and Pharmacology (3 papers) and Pharmacology and Obesity Treatment (2 papers). C. Alm collaborates with scholars based in Sweden, Slovakia and Tanzania. C. Alm's co-authors include Juliette Säwe, JO Svensson, Q-Y Yue, Folke Sjöqvist, Leif Bertilsson, M-L Dahl, L. Lindström, Sara Ramos, Ulf Bondesson and J. Benítez and has published in prestigious journals such as Alimentary Pharmacology & Therapeutics, Journal of Endocrinology and British Journal of Clinical Pharmacology.

In The Last Decade

C. Alm

15 papers receiving 735 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C. Alm Sweden 12 413 185 152 129 123 15 764
Edward J. Antal United States 19 280 0.7× 174 0.9× 306 2.0× 165 1.3× 113 0.9× 50 1.2k
J S Harmatz United States 16 336 0.8× 228 1.2× 192 1.3× 173 1.3× 145 1.2× 22 1.0k
K. Br�sen Denmark 11 478 1.2× 152 0.8× 242 1.6× 157 1.2× 220 1.8× 13 915
P Bechtel France 15 495 1.2× 126 0.7× 198 1.3× 110 0.9× 201 1.6× 55 935
Karin Kramer Nielsen Denmark 16 384 0.9× 130 0.7× 220 1.4× 105 0.8× 163 1.3× 28 921
David J. Greenblatt United States 11 492 1.2× 114 0.6× 180 1.2× 154 1.2× 244 2.0× 12 1.1k
Michael S. Ching Australia 18 295 0.7× 101 0.5× 134 0.9× 195 1.5× 170 1.4× 48 893
G. Alv�n Sweden 12 304 0.7× 88 0.5× 168 1.1× 102 0.8× 110 0.9× 17 664
Gilles Caillé Canada 20 210 0.5× 110 0.6× 357 2.3× 146 1.1× 128 1.0× 73 1.1k
Menger Chung United States 17 173 0.4× 194 1.0× 262 1.7× 102 0.8× 59 0.5× 29 891

Countries citing papers authored by C. Alm

Since Specialization
Citations

This map shows the geographic impact of C. Alm's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Alm with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Alm more than expected).

Fields of papers citing papers by C. Alm

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Alm. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Alm. The network helps show where C. Alm may publish in the future.

Co-authorship network of co-authors of C. Alm

This figure shows the co-authorship network connecting the top 25 collaborators of C. Alm. A scholar is included among the top collaborators of C. Alm based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Alm. C. Alm is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Devlin, Maureen J., Corinna Grasemann, Alison Cloutier, et al.. (2013). Maternal perinatal diet induces developmental programming of bone architecture. Journal of Endocrinology. 217(1). 69–81. 25 indexed citations
2.
Alm, C., Elba Lúcia Cavalcanti de Amorim, & Ulysses Paulino Albuquerque. (2011). Insights into the search for new drugs from traditional knowledge: An ethnobotanical and chemical–ecological perspective. Pharmaceutical Biology. 49(8). 864–873. 14 indexed citations
3.
Nsimba, Stephen E. D., et al.. (2008). Comparative in vitro and in vivo study of a sugar-coated chloroquine preparation marketed in Tanzania versus an ordinary brand. Journal of Clinical Pharmacy and Therapeutics. 26(1). 43–48. 1 indexed citations
4.
Nsimba, Stephen E. D., et al.. (2001). Comparative in vitro and in vivo study of a sugar-coated chloroquine preparation marketed in Tanzania versus an ordinary brand. Journal of Clinical Pharmacy and Therapeutics. 26(1). 43–48. 11 indexed citations
5.
Wennerholm, Agneta, Inger Johansson, Amos Massele, et al.. (1999). Decreased capacity for debrisoquine metabolism among black Tanzanians: analyses of the CYP2D6 genotype and phenotype.. PubMed. 9(6). 707–14. 59 indexed citations
6.
Yue, Q. Y., C. Alm, Jan Olof Svensson, & Juliette Säwe. (1997). Quantification of the O- and N-Demethylated and the Glucuronidated Metabolites of Codeine Relative to the Debrisoquine Metabolic Ratio in Urine in Ultrarapid, Rapid, and Poor Debrisoquine Hydroxylators. Therapeutic Drug Monitoring. 19(5). 539–542. 31 indexed citations
8.
Emanuelsson, B.‐M., Jan Persson, Sven Sandin, C. Alm, & Lars L. Gustafsson. (1997). Intraindividual and Interindividual Variability in the Disposition of the Local Anesthetic Ropivacaine in Healthy Subjects. Therapeutic Drug Monitoring. 19(2). 126–131. 35 indexed citations
9.
Dahl, Marja­‐Liisa, Gerrit Voortman, C. Alm, et al.. (1997). In Vitro and In Vivo Studies on the Disposition of Mirtazapine in Humans. Clinical Drug Investigation. 13(1). 37–46. 67 indexed citations
10.
Böttiger, Ylva, P. Dostert, M. Strolin Benedetti, et al.. (1996). Involvement of CYP2D6 but not CYP2C19 in nicergoline metabolism in humans. British Journal of Clinical Pharmacology. 42(6). 707–711. 11 indexed citations
11.
Bertilsson, Leif, M-L Dahl, Adrián LLerena, et al.. (1994). Clozapine disposition covaries with CYP1A2 activity determined by a caffeine test.. British Journal of Clinical Pharmacology. 38(5). 471–473. 234 indexed citations
12.
Dahl, Marja­‐Liisa, Lennart Iselius, C. Alm, et al.. (1993). Polymorphic 2-hydroxylation of desipramine. European Journal of Clinical Pharmacology. 44(5). 445–450. 21 indexed citations
13.
Alm, C., et al.. (1990). Lack of relationship between glibenclamide metabolism and debrisoquine or mephenytoin hydroxylation phenotypes.. British Journal of Clinical Pharmacology. 30(3). 476–480. 11 indexed citations
14.
Yue, Q-Y, JO Svensson, C. Alm, Folke Sjöqvist, & Juliette Säwe. (1989). Interindividual and interethnic differences in the demethylation and glucuronidation of codeine.. British Journal of Clinical Pharmacology. 28(6). 629–637. 99 indexed citations
15.
Yue, Q-Y, JO Svensson, C. Alm, Folke Sjöqvist, & Juliette Säwe. (1989). Codeine O‐demethylation co‐segregates with polymorphic debrisoquine hydroxylation.. British Journal of Clinical Pharmacology. 28(6). 639–645. 118 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026